HCAT241220C5000
- 3.25
- 0.000.00%
Health Catalyst Newsroom
Health Catalyst Analyst Ratings
Piper Sandler Maintains Health Catalyst(HCAT.US) With Buy Rating, Maintains Target Price $12
Piper Sandler Maintains Health Catalyst(HCAT.US) With Buy Rating, Raises Target Price to $12
J.P. Morgan Maintains Health Catalyst(HCAT.US) With Buy Rating, Cuts Target Price to $12
Health Catalyst (HCAT) Receives a Buy From J.P. Morgan
Stephens Maintains Health Catalyst(HCAT.US) With Hold Rating, Raises Target Price to $9
Citi Maintains Health Catalyst(HCAT.US) With Buy Rating, Raises Target Price to $10.5
Stifel Maintains Health Catalyst(HCAT.US) With Hold Rating, Raises Target Price to $10
Health Catalyst Is Maintained at Sector Perform by RBC Capital
Health Catalyst Analyst Ratings
CCORF Maintains Health Catalyst(HCAT.US) With Buy Rating, Maintains Target Price $11
Evercore Maintains Health Catalyst(HCAT.US) With Buy Rating, Maintains Target Price $10
RBC Capital Maintains Health Catalyst(HCAT.US) With Hold Rating, Raises Target Price to $9
BTIG Maintains Health Catalyst(HCAT.US) With Buy Rating, Maintains Target Price $13
Health Catalyst Poised for Growth: Strong Q3 Performance and Strategic Positioning Drive Buy Rating
Barclays Maintains Health Catalyst(HCAT.US) With Buy Rating, Maintains Target Price $14
Barclays Sticks to Their Buy Rating for Health Catalyst (HCAT)
Health Catalyst Is Maintained at Outperform by Evercore ISI Group
Evercore Maintains Health Catalyst(HCAT.US) With Buy Rating, Raises Target Price to $10
Health Catalyst Analyst Ratings